Fourier Intelligence

Headquarters: China

Filing date: 2027-06-25

Estimated valuation: $800.0M

Executive Summary

Fourier Intelligence, a Shanghai-based company, specializes in exoskeleton and humanoid robotics, specifically the GR-1, serving global rehabilitation and research markets. The company develops crucial technologies such as human-robot interfaces, robotic kinematics and dynamics, and high-performance joint modules. Fourier Intelligence is poised for significant growth in the rapidly expanding medical robotics market, driven by an aging global population and increasing demand for advanced rehabilitation solutions. The competitive landscape includes both established medical device companies and emerging robotics startups, with a potential IPO horizon between 2025 and 2029.

Risk Analysis

Detailed risk factors, AI-graded risk score, financials, and analyst commentary for Fourier Intelligence are available to Pro subscribers.

Unlock the full report or browse 500+ pre-IPO prospects.